Your source for the latest medtech news from AdvaMed and our members.
AdvaMed, the Medtech Association, announced that Peter J. Arduini, president and CEO of GE HealthCare, will become the Chair of the AdvaMed Board of Directors.
Neuspera Medical, Inc., a neuromodulation company pioneering the Neuspera Implantable Sacral Neuromodulation (SNM) System, today announced it has completed patient enrollment and implant procedures for the pivotal clinical trial (SANS-UUI)…
Today, AdvaMed, the Medtech Association, released the following statement from President and CEO Scott Whitaker on the recent actions to strengthen supply chains announced by President Biden as part of…
PhotoPharmics, an innovator in Parkinson’s disease research and treatment, today announced the successful first close of a $16 million investment round. The investment round, led by Kickstart Fund, a venture…
If you have media inquiries, please contact:
Cody Uhing, Director, Communications & Media Relations, 202-434-7233
AdvaMed, the Medtech Association, released this statement from President and CEO Scott Whitaker following the House Energy & Commerce Committee’s Subcommittee on Health markup of H.R. 1691, Ensuring Patient Access…
Today, AdvaMedDx, a division of AdvaMed representing manufacturers of innovative in vitro diagnostic tests, sent a letter urging Congressional leaders to prioritize the reauthorization of the President’s Emergency Plan for…
AdvaMed, the medtech association, today released the following statements on the White House’s announcement today of a new initiative focused on women’s health research to be led by First Lady…
As the International Civil Aviation Organization (ICAO) Dangerous Goods Panel meets this week, AdvaMed, the Medtech Association, led a group of 24 global medtech organizations in expressing concerns about the…
Brought to you by AdvaMed, Medtech POV with Scott Whitaker is a podcast that covers the intersection of medtech and policy from every perspective.
RIVANNA®, developers of world-first, imaging-based medical solutions, announced they received a $2.9 million grant from the National Institutes of Health (NIH). The grant will further the development of Accuro® 3S,…